BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15547233)

  • 21. Mucinous carcinoma of the breast: MRI features of pure and mixed forms with histopathologic correlation.
    Monzawa S; Yokokawa M; Sakuma T; Takao S; Hirokaga K; Hanioka K; Adachi S
    AJR Am J Roentgenol; 2009 Mar; 192(3):W125-31. PubMed ID: 19234240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced MRI of ductal carcinoma in situ: characteristics of a new intensity-modulated parametric mapping technique correlated with histopathologic findings.
    Mariano MN; van den Bosch MA; Daniel BL; Nowels KW; Birdwell RL; Fong KJ; Desmond PS; Plevritis S; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM
    J Magn Reson Imaging; 2005 Oct; 22(4):520-6. PubMed ID: 16142701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast magnetic resonance imaging in patients with occult breast carcinoma: evaluation on feasibility and correlation with histopathological findings.
    Lu H; Xu YL; Zhang SP; Lang RG; Zee CS; Liu PF; Fu L
    Chin Med J (Engl); 2011 Jun; 124(12):1790-5. PubMed ID: 21740834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.
    Su MY; Cheung YC; Fruehauf JP; Yu H; Nalcioglu O; Mechetner E; Kyshtoobayeva A; Chen SC; Hsueh S; McLaren CE; Wan YL
    J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of ductal carcinoma in situ in magnetic resonance imaging.
    Facius M; Renz DM; Neubauer H; Böttcher J; Gajda M; Camara O; Kaiser WA
    Clin Imaging; 2007; 31(6):394-400. PubMed ID: 17996602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
    Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
    Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of enhancement characteristics between invasive lobular carcinoma and invasive ductal carcinoma.
    Mann RM; Veltman J; Huisman H; Boetes C
    J Magn Reson Imaging; 2011 Aug; 34(2):293-300. PubMed ID: 21780225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.
    Kinkel K; Helbich TH; Esserman LJ; Barclay J; Schwerin EH; Sickles EA; Hylton NM
    AJR Am J Roentgenol; 2000 Jul; 175(1):35-43. PubMed ID: 10882243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision.
    Londero V; Zuiani C; Linda A; Girometti R; Bazzocchi M; Sardanelli F
    AJR Am J Roentgenol; 2012 Aug; 199(2):W240-50. PubMed ID: 22826427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Magnetic resonance imaging of breast cancer: correlation between contrast enhancement and tumor angiogenesis].
    Furuta A; Ishibashi T; Takahashi S; Yamada S; Ohuchi N; Amano G; Goto K; Watanabe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Oct; 59(12):682-8. PubMed ID: 10565172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast.
    Kelcz F; Furman-Haran E; Grobgeld D; Degani H
    AJR Am J Roentgenol; 2002 Dec; 179(6):1485-92. PubMed ID: 12438042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pure ductal carcinoma in situ: a range of MRI features.
    Raza S; Vallejo M; Chikarmane SA; Birdwell RL
    AJR Am J Roentgenol; 2008 Sep; 191(3):689-99. PubMed ID: 18716095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
    Gokalp G; Topal U; Yildirim N; Tolunay S
    Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Kubo M; Tokunaga E; Yamamoto H; Honda H
    Eur J Radiol; 2010 Jul; 75(1):e126-32. PubMed ID: 19796900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
    Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
    J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
    Yuen S; Uematsu T; Kasami M; Tanaka K; Kimura K; Sanuki J; Uchida Y; Furukawa H
    J Magn Reson Imaging; 2007 Mar; 25(3):502-10. PubMed ID: 17326093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.